WinstonWınston
Back
Niva Bupa Health Insurance Company Limited logo

Niva Bupa Health Insurance Company Limited

NIVABUPA.NS
39
Insurance - Life · Financial Services
Exchange
National Stock Exchange of India
Winston Score
39
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Weak
Stability
Exceptional
Valuation
Good

Winston Score History

The full picture

Niva Bupa Health Insurance Company Limited is an Indian health insurance company that sells medical coverage plans to individuals, families, and corporate clients. It offers products like individual health policies, family floater plans, and group insurance for employers. The company is a joint venture between Bupa, a major UK-based healthcare group, and Fettle Tone LLP (formerly True North), and operates exclusively in India's fast-growing private health insurance market.

Niva Bupa earns money primarily through insurance premiums paid by policyholders, either directly or through employer group plans. It sells policies through agents, brokers, banks, and its own digital channels across India. The company benefits from Bupa's global healthcare expertise and brand credibility, which helps it compete against larger state-owned insurers and well-established private rivals like Star Health. The key growth driver is India's large underinsured population and rising healthcare costs, though the main risk is keeping claims costs under control as medical inflation continues to climb.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+7.6% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+65.5% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

66.2%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

₹85.7B cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Niva Bupa Health Insurance Company Limited is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
13.9%
Thin — 13.9% gross margin
Profit after running costs
Operating Margin
7.4%
Modest — 7.4% operating margin
Return on the money invested
ROCE
11.7%
Below par — 11.7% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
2/5 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
0%
Weak — only 0% of profit becomes cash
Spare cash per sale
FCF Margin
0.0%
Thin free cash flow (0.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.08
Conservative — low debt load (0.08)
Covers its interest
Interest Cover
43.55x
Comfortably covers interest (43.5x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
42.7x
no trend
Pricey — P/E 42.7

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+22.9
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (42.7 → 19.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial